4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-19-026484
President and General Counsel sold 10,000 shares at $21.97 ($219,700)
- President and General Counsel acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shandell Jason B. President and General Counsel | 2019-05-01 | Option exercise | +10,000 | $10.93 | $109,300 | 169,947 | D |
| Shandell Jason B. President and General Counsel | 2019-05-01 | Sale | −10,000 | $21.97 | $219,700 | 159,947 | D |
| Derivatives | |||||||
| Shandell Jason B. President and General Counsel | 2019-05-01 | Option exercise · Employee Stock Option (right to buy) | −10,000 | 34,149 | D | ||
| Open-market sales · 10,000 sh · avg $21.97 · $219,700 | |||||||
Loading xslF345X03/a4.xml…